DermaPet

Articles of Interest

 

Medical Management Of Otitis Media
&
When To Go To Surgery

LSU SVM ANNUAL DERMATOLOGY SEMINARS
MARCH 2004

Carol S Foil MS DVM Dipl ACVD
Professor of Dermatology
Louisiana State University
School of Veterinary Medicine
Department of Clinical Sciences
cfoil@vetmed.lsu.edu
Dermatology Consultant – Veterinary Information Network

CHRONIC OTITIS EXTERNA

If chronic OE is ceruminous, treat as Dr. Merchant has outlined and look for underlying primary causes.

If chronic OE is purulent, and purulent exudate has been present for more than 6 weeks or if relapses have been occurring more than 6 months, there is >> 50% chance there is otitis media and, even if not, progressive pathologic changes will affect therapy.

PROGRESSIVE PATHOLOGIC CHANGES RECAP



STENOSIS of Horizontal Canal
: may be from edema, glandular proliferation, hidradenitis, folliculitis, furunculosis, fibrosis, mineralization of soft tissues.

TYMPANIC MEMBRANE: becomes thickened, may invaginate into middle ear dorsal to manubrium forming false middle ear, may be ruptured.

EPITHELIUM OF TYMPANIC BULLA: may become hyperplastic, metaplastic. May be eroded, scarred; may form inflammatory polyps

EXUDATE INSPISSATED IN MIDDLE EAR: may be mucoid or may be inspissated, may contain hair or keratin debris

BONEY TYMPANIC BULLA: may thicken, develop osteophytes, and, rarely, may develop osteitis.


WHAT DO I DO FOR INITIAL EVALUATION?

WHY IS GENERAL ANESTHESIA ALWAYS PART OF THE PLAN (IN MY OPINION)?

  1. Otitis Media is a Surgical Disease (more later) and the sooner it is discovered and treated, the better.

  2. You cannot expect to remove exudate from the horizontal canal in an awake or sedated animal. In fact, it takes a deeper plane of anesthesia to instrument the horizontal canal than for superficial soft tissue surgery!

  3. You cannot thoroughly evaluate the patency and health of the proximal horizontal canal and the tympanum without general anesthesia.

  4. . You cannot effectively medicate the proximal horizontal canal with topicals when exudate is present.


WHAT DO I DO WITH THE ANESTHETIZED PATIENT?

HOW DO I FOLLOW-UP WITH MEDICAL THERAPY?

COMMENTS:

  1. Formulate an initial prognosis based on the degree of stenosis, nodular hyperplasia and calcification and neurologic status. If any of these is severe or compromised, the ear will not be likely to respond to a medical approach. If the ear is deemed appropriate for surgery (see below) initial medical therapy should be continued up to the time of surgery, but the prednisone should be tapered down prior to surgical referral.

  2. Enrofloxacin, ciprofloxacin and marbofloxacin are difficult to compare as to efficacy. There are some dermatologists and pharmacologists who claim that there is data to support superior predicted efficacy with marbofloxacin owing to longer half-life. Others claim superior affordability for cipro even at 20 mg/kg, which is need for comparable efficacy. More data is needed before this issue can be settled.

  3. The high dosages recommended for enrofloxacin and marbofloxacin are based on the MIC90 values for Pseudomonas cultures studied.

  4. If the cultured Pseudomonas is truly resistant to the fluoroquinolones, then injectable antibiotics may be unitized. We have used either ceftazidime 30?50mg.kg BID; (500 mg vial $7.27) or ticarcillin 60?75mg.kg BID (3gm vial $13). Clients can give these injections at home, SQ for 2 -3 weeks.

  5. Alternatives for topical antimicrobials include polymixins, ticarcillin and amikacin.

  6. Tris-EDTA acts as a chelating agent and enhances activity of topical antibiotics against otic pathogens by decreasing stability and increasing permeability of the cell wall. A recent theory to explain resistance patterns in Pseudomonas involves the expression of one or more of three genes, called the MEX genes, selected for in resistant bacteria that cause an "efflux pump" mechanism to activate. The efflux pump causes antibiotics to be actively pumped out of the bacteria. When resistant Pseudomonas have their MEX genes removed, they once again become sensitive to fluoroquinolones. EDTA seems to inactivate these pumps thus restoring the antibiotic sensitivity. In-vitro treatment of highly fluoroquinolone resistant Pseudomonas (MIC>50mcg/ml) with tris-EDTA demonstrated significant reduction in the MIC after a 5-minute treatment

  7. Tris EDTA is compounded using 1.2 g EDTA, 6.05 g Tris buffer, 1 L distilled water, pH 8, and autoclaved 15 min. Many compounding pharmacies will prepare solutions for you, but a commercial veterinary preparation is available (TrizEDTA, DermaPet. The ear canal should be filled with the solution 15-30 min before the topical antibiotic every 12 hours if either polymixins or amikacin is chosen. Fluoroquinolones may be mixed into the Tris EDTA.

  8. Corticosteroids are used in order to decrease swelling and exudation in the ear canal to improve patency and visualization during the anesthetic procedure. This is the reason for the delay of 2 -3 days (or more) before ear flushing is scheduled. It is generally safe to do this initially in healthy dogs because the majority of the time, the infection is well treated with the empirical choice of fluoroquinolones. Since we have been using this technique and aggressive dosing of fluoroquinolones, we have had no cases where the infection was perceived to have been made worse by this treatment. The corticosteroids are continued for at least 2 weeks in order to reverse the hyperplastic changes in the ear canal and continue to suppress exudation. They should be continued for as long as 4 weeks, if the dog is tolerating this and the infection is coming under control.

  9. Bullae radiology requires excellent radiologic technique and positioning. If this is not the standard in your practice, then don=t bother doing them. They are not sensitive for diagnosis of otitis media (estimated only 50% have changes).

  10. This is a serious disease that is frequently under-treated in my experience. It is a surgical disease that we can now treat medically IN SOME CASES. It is an expensive disease, and I know of no way to make it less so and still have a chance at a satisfactory outcome. Any and all suggestions in this regard are welcome!

WHAT ARE THE INDICATIONS FOR MORE EXTENSIVE SURGICAL MANAGEMENT IN OTITIS CASES?

WHAT ARE THE INDICATIONS FOR THE SPECIFIC SURGICAL OPTIONS AVAILABLE?

WHAT ABOUT OTITIS MEDIA IN CATS?


WHAT ABOUT OTITIS MEDIA AND MALASSEZIA?

WHAT ABOUT THOSE TYMPANI THAT NEVER HEAL?


8909 Iverleigh Court Potomac, Maryland 20854
301-983-8387 800-755-4738 Fax 301-365-0191
E-mail dermapet@aol.com

Products || Protocols || Shampoo Therapy
Skin Diseases || 7 Steps to Treating Ears || Articles of Interest
About DermaPet || Newsletter || MSDS Sheets || Home